拉曼光谱对前列腺癌的介观表征:诊断与治疗潜力
研究采用手持式拉曼光谱探头对32例前列腺切除标本采集947个光谱,用神经网络分类。结果显示拉曼光谱可区分前列腺与前列腺外组织(敏感性82%、特异性83%)、良性与恶性组织(敏感性87%、特异性86%),并在探索性分析中区分良性组织与不同GG分级。
要点
- 拉曼光谱可区分前列腺与前列腺外组织,敏感性82%、特异性83%。
- 拉曼光谱可区分良性与恶性组织,敏感性87%、特异性86%。
- 探索性分析显示拉曼光谱可区分良性组织与GG1-GG5各级别。
核心结论
- 拉曼光谱结合光纤探头可高精度检测前列腺癌,为开发体内肿瘤靶向光谱工具、指导精准活检及辅助手术切除提供原理验证。
研究设计与样本
- 研究纳入32例新鲜未经处理的前列腺切除标本,使用宏观手持式拉曼光谱探头,每个测量区域采集20至50个光谱,共947个光谱。
- 测量区域按组织类型(前列腺外或前列腺)、组织恶性(良性或恶性)、癌症分级(GG1-5)及组织腺体水平进行组织病理学分类,数据采用神经网络机器学习分类分析。
主要发现
- 拉曼光谱区分前列腺与前列腺外组织的敏感性为82%、特异性为83%。
- 拉曼光谱区分良性与恶性组织的敏感性为87%、特异性为86%。
- 探索性分析中,拉曼光谱区分良性组织与GG1:726/801光谱(91%;敏感性80%,特异性91%)。
- 区分良性组织与GG2:588/805光谱(73%;敏感性76%,特异性73%)。
- 区分良性组织与GG3:670/797光谱(84%;敏感性86%,特异性84%)。
临床怎么用
- 拉曼光谱作为一种非破坏性组织 interrogation 技术,可提供振动分子信息,有望用于体内肿瘤靶向光谱工具开发,指导活检采集。
- 该技术可能作为组织病理学分析的补充,改善根治性前列腺切除术中的手术切除。
局限性
- 研究为原理验证性,样本量有限(32例),需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test if Raman spectroscopy (RS) is an appropriate tool for the diagnosis and possibly grading of prostate cancer (PCa). PATIENTS AND METHODS: Between 20 and 50 Raman spectra were acquired from 32 fresh and non-processed post-prostatectomy specimens using a macroscopic handheld RS probe. Each measured area was characterized and categorized according to histopathological criteria: tissue type (extraprostatic or prostatic); tissue malignancy (benign or malignant); cancer grade (Grade Groups [GGs] 1-5); and tissue glandular level. The data were analysed using machine-learning classification with neural network. RESULTS: The RS technique was able to distinguish prostate from extraprostatic tissue with a sensitivity of 82% and a specificity of 83% and benign from malignant tissue with a sensitivity of 87% and a specificity of 86%. In an exploratory fashion, RS differentiated benign from GG1 in 726/801 spectra (91%; sensitivity 80%, specificity 91%), from GG2 in 588/805 spectra (73%; sensitivity 76%, specificity 73%), from GG3 in 670/797 spectra (84%; sensitivity 86%, specificity 84%), from GG4 in 711/802 spectra (88%; sensitivity 77%, specificity 89%) and from GG5 in 729/818 spectra (89%; sensitivity 90%, specificity 89%). CONCLUSION: Current diagnostic approaches of PCa using needle biopsies have suboptimal cancer detection rates and a significant risk of infection. Standard non-targeted random sampling results in false-negative biopsies in 15-30% of patients, which affects clinical management. RS, a non-destructive tissue interrogation technique providing vibrational molecular information, resolved the highly complex architecture of the prostate and detect cancer with high accuracy using a fibre optic probe to interrogate radical prostatectomy (RP) specimens from 32 patients (947 spectra). This proof-of-principle paves the way for the development of in vivo tumour targeting spectroscopy tools for informed biopsy collection to address the clinical need for accurate PCa diagnosis and possibly to improve surgical resection during RP as a complement to histopathological analysis.
引用
- Aubertin K, Trinh VQ, Jermyn M, et al. Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics. BJU Int. 2018. PMID: 29542855. doi:10.1111/bju.14199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。